Veterinary Medicines

Gallimune SE + ST

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
Download as PDF

Product identification

Medicine name:
Gallimune SE + ST
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
Target species:
  • Chicken (for reproduction)
  • Chicken (pullet for egg production, future layer)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain DT104, Inactivated
    71.00
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain PT4, Inactivated
    142.00
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
    • Chicken (pullet for egg production, future layer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120335
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."